NCT00772278

Brief Summary

Purpose of this study: Primary:

  • Comparison of cardiovascular mortality and morbidity which includes cardiac and neurological morbidity (TIA and CVA) in the two invasive treatments of asymptomatic carotid artery stenosis Secondary:
  • Comparison of non cardiovascular morbidity caused by the two invasive techniques
  • morbidity at the site of incision (infection or local hematoma)
  • damage to cranial nerves (hypoglossus, vagus)
  • brain hyperperfusion which is defined as severe headache which is not responsive to analgesics with or without nausea and vomiting.
  • events of bradycardia within the first 24 hours, clinically evident and/or silent
  • microembolic brain events immediately after the procedure and their relationship with morbidity and/or mortality due to TIA's or CVA's
  • the change in the stenotic carotid artery at the time of follow up with duplex of neck arteries
  • the comparison of the affect of the two procedures on patient life style

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jan 2009

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2008

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 15, 2008

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

July 25, 2017

Status Verified

July 1, 2017

Enrollment Period

6.7 years

First QC Date

September 29, 2008

Last Update Submit

July 24, 2017

Conditions

Keywords

carotid stenosisasymptomaticcarotid stentingcarotid endarterectomy

Outcome Measures

Primary Outcomes (1)

  • comparison of cardiovascular mortality and morbidity which includes cardiac and neurological morbidity (TIA and CVA) in the two invasive treatments of asymptomatic carotid artery stenosis

    2 years

Secondary Outcomes (7)

  • incision site morbidity

    2 years

  • cranial nerves damage

    2 years

  • brain hyperperfusion

    2 years

  • bradycardia within the first 24 hours

    2 years

  • microembolic brain events

    2 years

  • +2 more secondary outcomes

Study Arms (2)

CAS

ACTIVE COMPARATOR

carotid artery stenting

Procedure: carotid artery stenting

CEA

ACTIVE COMPARATOR

carotid endarterectomy

Procedure: carotid endarterectomy

Interventions

carotid artery angiography, angioplasty and stenting

Also known as: carotid stent - precise - rapid exchange® (Cordis, FL, USA), carotid artery filter - angioguard® (Cordis, FL, USA)
CAS

open surgery including endarterectomy

CEA

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stenosis of 70% or more by carotid artery duplex, CTA or MRA.
  • No evidence of TIA or CVA originating in area of the brain supplied by the carotid artery under study, in the four months preceding treatment.
  • Eligibility for both treatment options:
  • suited for operative treatment as assessed by an anesthesiologist
  • suited for endovascular procedure by established radiological guidelines (including: access to the stenotic area via the vessels of the aortic arch, the absence of occlusion preventing this access, absence of significant atherosclerosis within the arch of aorta, absence of torturous anatomy of the common and internal carotid artery, and absence of thrombus in the area of stenosis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Medical Center

Haifa, 34362, Israel

Location

MeSH Terms

Conditions

Carotid Stenosis

Interventions

Endarterectomy, Carotid

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EndarterectomyVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Dallit Mannheim, Dr.

    Carmel Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 29, 2008

First Posted

October 15, 2008

Study Start

January 1, 2009

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

July 25, 2017

Record last verified: 2017-07

Locations